EFFECTS OF CONTINUOUS DAILY ADMINISTRATION OF 0.03 mg OF d-NORGESTREL ON THE PLASMA LEVELS OF PROGESTERONE AND THE URINARY EXCRETION OF OESTROGENS

1971 ◽  
Vol 66 (4) ◽  
pp. 702-710 ◽  
Author(s):  
U. Larsson-Cohn ◽  
E. D. B. Johansson ◽  
C. Gemzell

ABSTRACT Daily determinations of the plasma level of progesterone and the urinary excretion of oestrogens were performed in five subjects during one control cycle followed by three months of treatment with 0.03 mg of d-norgestrel. The control cycles were ovulatory according to the parameters investigated, although one of the women showed a monophasic basal body temperature. During treatment there was a tendency to a decrease of the oestrogen excretion. Three of the women showed one or several cycles with low progesterone levels. It is believed that this was due to a defective function of the corpus luteum. It seems that the effect of the present drug on the corpus luteum activity was about equal to that of chlormadinone acetate 0.5 mg daily, while 0.3 and 0.5 mg of norethindrone depressed the function more markedly.

1970 ◽  
Vol 64 (1) ◽  
pp. 38-46 ◽  
Author(s):  
U. Larsson-Cohn ◽  
E. D. B. Johansson ◽  
C. Gemzell

ABSTRACT Daily determinations of the plasma level of progesterone and the urinary excretion of total oestrogens and pregnanediol were performed in 7 subjects during one control cycle, followed by three months of daily continuous treatment with 0.3 mg of norethindrone (NET). The control cycles were ovulatory according to the parameters investigated. During treatment there was a tendency to cyclically increased oestrogen excretion, this being most marked in cycles with very depressed progesterone-pregnanediol levels. All the subjects showed signs of cyclical luteal activity. In most cases, the levels of progesterone and pregnanediol were lower than during the corresponding control cycles. It is suggested that this might be due to deficient corpus luteum function. The drug had no thermogenic effect. The length of the treatment cycles varied between 22 and 49 days. Only two of the women showed intermenstrual bleeding. It seems that 0.3 mg of NET has a weaker effect on the hormone levels than 0.5 mg of NET, but a stronger effect than 0.5 mg of chlormadinone acetate.


1970 ◽  
Vol 63 (4) ◽  
pp. 705-716 ◽  
Author(s):  
U. Larsson-Cohn ◽  
E. D. B. Johansson ◽  
L. Wide ◽  
C. Gemzell

ABSTRACT Daily determinations of the plasma level of progesterone and the urinary excretion of luteinizing hormone (LH) and total oestrogens were performed in 6 subjects during one control cycle, immediately followed by three cycles of daily treatment with 0.5 mg of chlormadinone acetate continuously. The control cycles were ovulatory according to the parameters investigated. Two of the women showed a normal LH excretion pattern in all treatment cycles. The four other subjects also had periodical variations in the LH excretion but no distinct midcycle peaks occurred. The mean oestrogen excretion was increased in all three treatment cycles but the difference was satistically significant only in the last two cycles. Compared with the treatment cycles, the sum of progesterone values was significantly decreased in the first two cycles. Chlormadinone acetate in this dose had no thermogenic effect. Three of the subjects showed bleeding irregularities which had no clear connection with the hormone variations measured in the study. It is suggested that the low levels of progesterone might be due to a defective corpus luteum function.


1969 ◽  
Vol 62 (1) ◽  
pp. 82-88 ◽  
Author(s):  
Elof D. B. Johansson ◽  
Leif Wide

ABSTRACT Plasma LH and progesterone levels were measured around the time of ovulation in 16 normal menstrual cycles. No increased levels of progesterone were found before the LH peak. The maximal LH peak levels lasted for 16–20 h at which time the plasma progesterone rose to a concentration of 1 to 2 ng/ml. Following the fall in the LH concentration, there was a rapid rise in the plasma progesterone concentration, indicating the formation of a corpus luteum. The lowest basal body temperature coincided with the first significant rise in LH levels.


1972 ◽  
Vol 54 (1) ◽  
pp. 119-123 ◽  
Author(s):  
J. WATSON

SUMMARY Plasma levels of luteinizing hormone (LH) in normally cyclic women during the menstrual cycle and in rats during the oestrous cycle were measured by bioassay. With the human subjects, it was possible to establish a mid-cycle peak of LH and correlate it with basal body temperature, while with the rats a peak of LH secretion was noted between 15.00 and 19.00 h on the day of pro-oestrus. The levels of LH in both groups of subjects were of the same order as those measured by other assay techniques.


1975 ◽  
Vol 3 (2) ◽  
pp. 63-72
Author(s):  
L Varga ◽  
E Tamme

The effects on pituitary-ovarian function of long-term administration of 0·5 mg of lynestrenol and 0·35 mg of norethisterone in continuous daily doses were investigated in 9 female subjects. The parameters employed were the basal body temperature charts and urinary assays of LH, total oestrogen and pregnanediol. At the start of administration, ovulation was usually inhibited, but as a rule this effect disappeared as administration continued. Corpus luteum function appeared to be reduced.


1970 ◽  
Vol 63 (2) ◽  
pp. 216-224 ◽  
Author(s):  
U. Larsson-Cohn ◽  
E. D. B. Johansson ◽  
L. Wide ◽  
C. Gemzell

ABSTRACT Daily determinations of the plasma level of progesterone and the urinary excretion of LH, total oestrogens and pregnanediol were performed in 4 subjects during one control cycle, immediately followed for 2 or 3 months of daily treatment with 0.5 mg of norethindrone continuously. The control cycles were ovulatory according to all the parameters investigated. During treatment the mid-cycle LH peak disappeared in all cases while the basal LH excretion showed considerable day to day variations. The excretion of total oestrogens was increased in all subjects but did not show the normal biphasic pattern. Periods of increased oestrogen excretion also appeared in the subjects with consistently low progesterone and pregnanediol levels during the treatment. In two cases, all signs of luteal activity immediately disappeared after the commencement of treatment. The other cases had one and three periods of increased progesterone and pregnanediol levels respectively. However, these periods were shorter than those of the control cycles. One of the subjects had regular menstrual bleeding while the other three had more or less irregular vaginal flows, often appearing during elevated but declining oestrogen excretion.


1984 ◽  
Vol 41 (2) ◽  
pp. 254-259 ◽  
Author(s):  
Jacques de Mouzon ◽  
Jacques Testart ◽  
Brigitte Lefevre ◽  
Jean-Luc Pouly ◽  
René Frydman

Sign in / Sign up

Export Citation Format

Share Document